9/26/2013

The European Commission approved the use of Gilead Sciences' Tybost, or cobicistat, as a boosting agent for certain protease inhibitors used in the treatment of HIV/AIDS. Tybost is part of Gilead's combination HIV-1 pill Stribild.

Related Summaries